Adherence to pediatric acute chemotherapy-induced nausea and vomiting guidelines in Canadian hospitals

Krista McKinnon1, Jennifer Jupp1, Sunita Ghosh2

  • 1Pharmacy Services, Alberta Children's Hospital, Alberta Health Services, Calgary, Canada.

Pediatric Blood & Cancer
|October 16, 2018
PubMed

Insights

Pediatric cancer patients show low adherence to chemotherapy-induced nausea and vomiting (CINV) guidelines. This resulted in poor CINV control, highlighting a need for improved treatment strategies in pediatric oncology care.

Area of Science:

  • Pediatric Oncology
  • Clinical Pharmacy
  • Evidence-Based Medicine

Background:

  • Chemotherapy-induced nausea and vomiting (CINV) significantly affects pediatric cancer patients' quality of life.
  • Recent guidelines for CINV classification and prevention in children have been endorsed by major pediatric oncology organizations.

Purpose of the Study:

  • To evaluate the adherence rates to pediatric CINV guidelines across four Canadian pediatric oncology centers.
  • To assess the impact of guideline adherence on CINV control in children receiving highly or moderately emetogenic chemotherapy.

Main Methods:

  • A multicenter chart review was conducted for 204 pediatric patients receiving their first chemotherapy course (highly emetogenic chemotherapy [HEC] or moderately emetogenic chemotherapy [MEC]) between 2012 and 2015.
  • Guideline adherence was assessed based on antiemetic-only guideline adherence (AGA) and complete guideline adherence (CGA), considering medication, dose, frequency, and duration.

Main Results:

  • Overall guideline adherence was low: 29% for AGA and 2% for CGA.
  • Vomiting occurred in 24% of AGA patients versus 34% of non-AGA patients (P=0.13).
  • Complete CINV control in the first 24 hours was achieved by 37% of HEC AGA patients vs. 45% of non-AGA patients (P=0.31), and 80% of MEC AGA patients vs. 24% of non-AGA patients (P=0.02).

Conclusions:

  • Adherence to pediatric CINV guidelines was suboptimal across participating institutions.
  • Varied implementation strategies for CINV guidelines were observed among centers.
  • Low complete CINV control rates and high instances of emesis indicate that pediatric patients are not receiving optimal antiemetic treatment.
Abstract

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
783
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
668
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
884
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
622
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.6K